Testing tirbanibulin cream for certain actinic keratoses
Part of Cancer, Skin clinical trials.
This study tests whether tirbanibulin (Klisyri) cream works well on specific types of actinic keratosis on the scalp or face that have a downward growth pattern. It helps doctors understand if this treatment is right for those skin spots.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have at least one actinic keratosis on your scalp or face that is not thick or scaly, and your doctor has already decided to treat it with Klisyri cream.
- You are not pregnant, cannot become pregnant, or are postmenopausal or surgically sterile.
- You have not had another treatment for actinic keratosis in the area within the last 3 months (such as cold therapy, other creams, or light therapy).
- You are not currently taking cancer medication or medications that suppress your immune system (like prednisone) within the last 8 weeks.
- You are not using other topical products (like retinoids, steroids, or glycolic acid) on the treatment area within the last 4 weeks.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a cream called tirbanibulin (Klisyri) for adults with 4 to 12 actinic keratosis (AK) spots on their face. It aims to see how well the treatment works when applied to a larger area of the face in everyday medical practice.
This trial tests how a new drug works in people with actinic keratosis (rough, scaly patches caused by sun damage) on their upper arms or face. You will receive the treatment and have blood samples taken to see how your body processes the medication.
This trial tests an ointment called HW211026 for people with actinic keratosis, a common skin condition caused by sun damage. The study will check if the ointment is safe and works when applied to a 10 cm by 10 cm area on the face.
This study tests a new sunscreen (Anthelos Fluide 100 KA+ UVMune 400) to see if it can protect skin and prevent further sun damage in people who already have multiple actinic keratoses (precancerous spots). It may help reduce the risk of new spots or skin cancer.
This study tests if a moisturizing cream called Lipikar Baume AP+M can help with actinic keratoses (rough, scaly spots caused by sun damage) on the forearms or backs of the hands. You'll use the cream on one arm and compare it to the other arm to see if it makes a difference.
This trial tests whether applying a 30% urea cream (Lipikar) before Tolak® treatment helps treat actinic keratoses (rough, scaly spots) on the scalp. It may make the skin more receptive to the treatment.
Hear when a new Actinic Keratosis (AK) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.